Clinical added value of drugs: An empirical survey of French transparency committee opinions.
Sign Up to like & getrecommendations! Published in 2018 at "Therapie"
DOI: 10.1016/j.therap.2018.10.004
Abstract: OBJECTIVES To identify criteria used by French health authorities to assess the clinical added value (ASMR) of drugs seeking reimbursement. METHODS We conducted a systematic review of the opinions of the transparency committee (TC) of… read more here.
Keywords: transparency committee; added value; asmr; french transparency ... See more keywords
Development, testing, and implementation of a new procedure to assess the clinical added benefit of pharmaceuticals
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Technology Assessment in Health Care"
DOI: 10.1017/s0266462322000411
Abstract: Abstract Objectives The reimbursement process for innovative health technologies in Hungary lacks any formalized assessment of clinical added benefit (CAB). The aim of this research is to present the development, retrospective testing, and implementation of… read more here.
Keywords: oncology; added benefit; clinical added; benefit ... See more keywords